{"id":"W4416405197","doi":"10.1016/j.euo.2025.09.010","title":"Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Abiraterone; Olaparib; Placebo; Prostate cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00284533,0.0008776492,0.001974892,0.0003389491,0.0003414014,0.0008055964,0.0005976896,0.0009062743,0.001948033],"category_scores_gemma":[0.001902156,0.0002988287,0.002837737,0.0004711275,0.0004114272,0.0005619928,0.0003773121,0.001861985,0.000287007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005484437,"about_ca_system_score_gemma":0.001001542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006071225,"about_ca_topic_score_gemma":0.001228086,"domain_scores_codex":[0.9990187,0.0006013997,0.00005536326,0.00009217373,0.0001329146,0.00009949491],"domain_scores_gemma":[0.9984566,0.000349009,0.0005436847,0.00008052272,0.000114643,0.0004555036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9382592,0.005501018,0.02354877,0.0006144982,0.003999144,0.00007891821,0.00008799002,0.0009181827,0.001800408,0.00006666846,0.001312823,0.02381229],"study_design_scores_gemma":[0.6676569,0.207759,0.1140231,0.0001532765,0.004464083,0.0002137735,0.0001247899,0.001450693,0.001323422,0.0003378665,0.002420817,0.00007226433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902445,0.005911866,0.0002333952,0.0003452983,0.0001520059,0.0006222293,0.0017399,0.00002696998,0.0007236914],"genre_scores_gemma":[0.9946691,0.001341393,0.0003160686,0.000417931,0.0001596716,0.0008311523,0.001819398,0.000005697977,0.0004394683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00284533,"threshold_uncertainty_score":0.01504773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06114573341904889,"score_gpt":0.3886800800726639,"score_spread":0.327534346653615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}